United States · FDA National Drug Code directory
Nexlizet
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72426-818_29da37de-60f3-4dcc-8ccd-1b96631778bd
- Product NDC
- 72426-818
- Form
- TABLET, FILM COATED
- Composition / generic term
- Bempedoic Acid and Ezetimibe
- Labeler
- Esperion Therapeutics, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200309
- Source listing expiry
- 20271231
Source-listed ingredients
- BEMPEDOIC ACID — 180 mg/1
- EZETIMIBE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72426-818-03) · 72426-818-03
- 7 TABLET, FILM COATED in 1 BLISTER PACK (72426-818-99) · 72426-818-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →